Bicara Therapeutics Inc.
Bicara Therapeutics Inc. (BCAX) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 73 transactions totaling $40.0M, demonstrating a bullish sentiment with $28.5M in net insider flow. The most recent transaction on Dec 26, 2025 involved a transaction of 19,789 shares valued at $75.0K.
BCAX Insider Activity Summary
Who Is Buying BCAX Stock?
No significant insider buying has been recorded for BCAX in the recent period.
Who Is Selling BCAX Stock?
No significant insider selling has been recorded for BCAX in the recent period.
Is Bicara Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for BCAX is bullish with an Insider Alignment Score of 86/100 and a net flow of $28.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
BCAX Frequently Asked Questions
Understanding BCAX Insider Activity
Insider trading at Bicara Therapeutics Inc. (BCAX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading BCAX stock, having executed 73 transactions in the past 90 days. The most active insider is Capital Nexus Fund Iii, L.p. Ra (Executive), who has made 4 transactions totaling $33.0M.
Related Tools
Track Bicara Therapeutics Inc. Insider Activity
Get notified when executives and directors at BCAX file new Form 4 transactions